Effectiveness of C1-INH therapy in angiotensin converting enzyme inhibitor induced angioedema
Abstract Introduction Angiotensin Converting Enzyme Inhibitors (ACEI) are a common cause of Emergency Room presentation for angioedema. Although no treatment guidelines exist, C1 esterase inhibitor concentrate (C1-INH) is used on an off label basis for management of ACEI acquired angioedema (ACEI AA...
Main Authors: | Uliana Kovaltchouk, Boyang Zhang, Vipul Jain, Chrystyna Kalicinsky |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Online Access: | https://doi.org/10.1186/s13223-021-00521-w |
Similar Items
-
Angiotensin-converting Enzyme Inhibitors-induced Angioedema
by: Chiriac Anca, et al.
Published: (2018-03-01) -
Angioedema secondary to angiotensin converting enzyme inhibitors
by: Thiruventhiran, T., et al.
Published: (1999) -
Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors
by: Janković Slobodan M., et al.
Published: (2011-01-01) -
Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
by: Ana Maria Oliveira, et al.
Published: (2016-05-01) -
Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor
by: Lundy McKibbin, et al.
Published: (2019-11-01)